# Proton Therapy With Chemotherapy for Stage III Non-Small Cell Lung Cancer (LU02)

> **NCT00881712** · NA · TERMINATED · sponsor: **University of Florida** · enrollment: 15 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **RADIATION:** PET positive nodal disease measuring 15 mm or greater
- **RADIATION:** PET positive nodal disease measuring less than 15 mm
- **RADIATION:** Patients considered resectable

## Key facts

- **NCT ID:** NCT00881712
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-06
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** projected enrollment rate not feasible
- **Last updated:** 2017-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00881712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00881712, "Proton Therapy With Chemotherapy for Stage III Non-Small Cell Lung Cancer (LU02)". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00881712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*